Sophion Introduces QPatch HTX – Automated Patch Clamp System

Date Posted: Thursday, February 19, 2009

Print Email to a friend

Sophion Bioscience A/S will introduce a new addition to the QPatch family at the 53rd annual meeting of the Biophysical Society in Boston. The Company’s new QPatch HTX increases the throughput and decreases the cost per data point for automated patch clamp screening.

With QPatch HTX Sophion further enables the use of giga-seal patch clamping for compound screening within ion channel drug discovery. QPatch HTX can be applied to all types of ion channels, including ligand-gated and voltage-gated channels. Data from the new system will be shown at Sophion’s QPatch User Meeting during the Biophysical Society’s conference, and more details will be provided at this time.

“An important part of Sophion’s business model has always been innovation through product development,” says Dr. Torsten Freltoft, CEO at Sophion Bioscience. “The strength of the QPatch HTX is its unsurpassed flexibility. Besides being able to run in a screening mode with higher throughput, QPatch HTX can still run all the same high quality assays as our existing systems, QPatch HT and QPatch 16.”

Sophion will have an exhibit at the Biophysical Society conference. Conference attendees may visit the Sophion booth to know more about QPatch HTX and to learn more about the QPatch and the QPatch Assay Software in general.

The company says that the QPatch HTX will be ready for shipment in Q4 2009. Upgrades of existing QPatch HT systems to QPatch HTX are available at the same time.

Further Information:

Request Information From Vendor

Related news from our archive

Sophion and ChanTest Announce Ion Channel Cell Line Collaboration
Sophion gains the right to provide ion channel cell lines from ChanTest that are optimized for Sophion’s QPatch automated patch clamp systems.

Sophion announces the first commercial CHO-hERG cell line optimized for the QPatch automated patch clamp system
Sophion Bioscience A/S has announced an agreement with bSys that allows Sophion to sell a CHO-hERG cell line fully optimized for and validated on the QPatch automated patch clamp system.

Sophion Installs QPatch at University of British Columbia Academic Laboratory
The QPatch will allow researchers to perform high-quality ion channel pharmacological and biophysical experiments.

Sophion Bioscience Collaborates with Merck
The collaboration aims to complete the QPatch HT, a 48-channel automated, gigaseal patch clamp system.